Barriers, facilitators, and solutions to familial hypercholesterolemia treatment.

Laney K JonesAmy C SturmTerry L SeatonChristina GregorSamuel S GiddingMarc S WilliamsAlanna Kulchak Rahm

Published in: PloS one (2020)

Proposed solutions to improve treatment of FH proffered by participants in this study included resources for both patients and clinician stakeholders that clarify cardiovascular disease risks from FH, develop programs to screen for and identify FH at younger ages, and foster open conversations between patients and clinicians about treatment.

Keyphrases

cardiovascular disease
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
public health
patient reported outcomes
high throughput
combination therapy
replacement therapy